We provide women with regular, preventative gynecological check-ups as well as treatment for a variety of female reproductive-related diseases.

RANGE OF GYNECOLOGICAL SERVICES

1. Preventive gynecological check-ups

• Pap smear, contraception advice, menopausal hormone replacement therapy, family planning advice.
• Early pregnancy: ultrasonography to check fetal number and viability, as well as initial pregnancy care.

2. Specialized gynecological checkups

• Lower genital tract illnesses like bacterial vaginosis, persistent fungal infections, and sexually transmitted diseases.
• Cervical diseases like colposcopy evaluation of cervical lesions on pathological smears, guidance, and referral for therapy.
• Benign uterine illnesses, including abnormal bleeding: ultrasound morphological examination of benign uterine tumors (fibroids, adenomyosis, polyps), counseling, commencement of conservative treatment, and/or referral for treatment.
• Adnexal cysts/tumors: morphological assessment of adnexal lesions by ultrasound, assessment of vascularity and detection of pathological flow by Doppler, counseling, conservative treatment, and/or referral for treatment.
• Persistent pelvic pain: palpation and ultrasound assessment of persistent pain causes (perineal, endometriosis, varicocele), counseling, conservative management, and/or referral for therapy.
• Pelvic floor static disorders and urine incontinence, counseling, cautious management, and/or referral to treatment.
• Combined female genital tract problems, counseling, cautious management, and/or referral to therapy.- Post-operative follow-up is primarily for patients with early-stage gynecological malignancies.

3. A second opinion on the appropriate treatment for previously identified female genital tract disorders.

4. Gynecological care for children, adolescent girls, reproductive-aged women, and menopausal women.

5. Individual hormone treatment.

6. Laser vaginal rejuvenation and therapy for stress urine incontinence.

Vulvovaginal dystrophy (VVD) is a disorder that develops in women following the loss of hormonal function. It is distinguished by decreased vascularization, lubrication, and flexibility of the vaginal mucosa. All of this results in painful intercourse, as well as symptoms of genitourinary syndrome (frequent urination, urgency, and incontinence). Some of these symptoms may occur before menopause, particularly with the number of births, recurrent vaginal infections, or following oncological treatment. Local hormone replacement can help improve the issue.

Laser vaginal rejuvenation can help women who have a loose vagina and leaks after childbirth. The laser warms the vaginal wall, causing the collagen to shrink. This contributes to the quality of the vaginal wall and bladder. The treatment is painless and doesn’t require anesthesia. Vaginal rejuvenation consists of three phases, the last of which involves infusing your plasma into the vagina to induce the production and proliferation of new cells.

7. Autologous plasma therapy.

Autologous plasma treatment (PRP method) is a procedure in which the patient’s blood is drawn and centrifuged in a specialized machine. We aid older patients with external genital difficulties, pain, incapacity to have sex, etc. by injecting our platelet-rich plasma into them.

Tests for genetic and chromosomal abnormalities

NIPT Prenatal Test

NIPT testing has advanced significantly from the original logarithms and platforms. Illumina remains the world’s top platform, utilizing the most modern massively parallel sequencing technology to analyze millions of DNA fragments in a blood sample and reliably compute the number of chromosomes present. The human genetic code (DNA) is stored on 23 pairs of chromosomes. The Safer Count method detects a shortage or excess of chromosomes. An excess or lack of one pair results in an abnormality/trisomy/monosomy, which can lead to organ malfunction, sickness, or intellectual incapacity. Our myPrenatal NIPT test uses the same technology and technique as described above.
It eliminates intrusive diagnostic methods (amniocentesis and chorionic villus biopsy, both of which involve the risk of infection and consequent miscarriage) and is 99% accurate. It’s safe, quick, and straightforward. You will receive the test result after collecting 7-10 ml of maternal blood and delivering it to the Illumina laboratory in the United States within 3-5 days. The myPrenatal test is perfectly safe for both – a pregnant woman and her baby. It can be done as early as the tenth week of pregnancy, letting you learn about your baby’s genetic health.

When and for whom is myPrenatal Test an appropriate choice?

For all pregnant women who have had a previous miscarriage, are at high risk on nuchal translucency scans or other screening tests, are over 35 years old, have an ultrasound scan that indicates an increased risk of aneuploidy (sex chromosome abnormalities), have had a previous chromosomal trisomy, or are simply concerned about the health of their baby’s chromosomes.

BRCA1/BRCA2

Despite breakthroughs in surgical procedures and the advent of new cytotoxic medications, ovarian cancer is still the leading cause of gynecological cancer in women. According to the Cancer Registry of the Republic of Slovenia, 169 women (16.4/100,000) got ovarian cancer, and 149 women (14.5/100,000) died from it between 2007 and 2011. Epithelial tumors account for up to 95% of ovarian malignancies and can be caused by mutations in the BRCA 1 or 2 genes in 5-10% of people, resulting in hereditary breast and ovarian cancer syndrome. The most prevalent histological type, high-grade serous adenocarcinoma, is more likely to have a mutation in the BRCA 1 or 2 genes (13-22%). A mutation in the BRCA 1 or 2 genes can be present in all cells of the body (germline) or can arise in tumor cells (somatic). In addition to this hereditary syndrome, ovarian cancer can also be associated with hereditary bowel cancer and some other rare hereditary syndromes.

The myBRCA screening test reliably detects mutations in the BRCA 1 and 2 genes, as well as 16 additional gene variants that cause colorectal, endometrial, prostate, melanoma, pancreatic, gastric, and hereditary cancer syndromes (Cowden, Lynch, Peutz-Jeghers, and Li-Fraumeni syndrome). Family history and the BRCA gene mutation are two of the few known risk factors for ovarian cancer. These people can benefit from an early detection strategy and have a lower risk of getting advanced cancer. Testing with myBRCA and myBRCA HiRisk assists us in accomplishing this.